Risk Factors for Disease Progression in Advanced Jejunoileal Neuroendocrine Tumors

Neuroendocrine tumors of midgut and hindgut origin: Tumor-node-metastasis classification determines clinical outcome

(2011) Henning Jann et al.   CANCER

Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting

(2011) Matthew H. Kulke et al.   JOURNAL OF CLINICAL ONCOLOGY

Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease Progression

(2011) Francesco Panzuto et al.   JOURNAL OF CLINICAL ONCOLOGY

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

(2011) Eric Raymond et al.   NEW ENGLAND JOURNAL OF MEDICINE

Everolimus for Advanced Pancreatic Neuroendocrine Tumors

(2011) James C. Yao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Carcinoid Tumors of the Gastrointestinal Tract: Trends in Incidence in England Since 1971

(2010) Libby Ellis et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)

(2010) R. Garcia-Carbonero et al.   ANNALS OF ONCOLOGY

Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters

(2010) Martin B Niederle et al.   ENDOCRINE-RELATED CANCER

Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients

(2010) Aldo Scarpa et al.   MODERN PATHOLOGY

Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma

(2009) Cosimo Durante et al.   ENDOCRINE-RELATED CANCER

Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study

(2009) A Ahmed et al.   ENDOCRINE-RELATED CANCER

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

(2009) Anja Rinke et al.   JOURNAL OF CLINICAL ONCOLOGY

Small intestinal neuroendocrine tumors: Prognostic factors and survival

(2009) Deidi Strickland Bergestuen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours

(2008) R. Bettini et al.   ANNALS OF ONCOLOGY

Prognostic Factors and Survival in 324 Patients with Pancreatic Endocrine Tumor Treated at a Single Institution

(2008) S. Ekeblad et al.   CLINICAL CANCER RESEARCH

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours

(2008) U.-F. Pape et al.   ENDOCRINE-RELATED CANCER

Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors

(2008) Stefano La Rosa et al.   HUMAN PATHOLOGY

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

(2008) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY

Gastroenteropancreatic neuroendocrine tumours

(2008) Irvin M Modlin et al.   LANCET ONCOLOGY